Ikonisys

Ikonisys Inventory

The Inventory of Ikonisys (ALIKO.PA) as of Oct 21, 2026 is 730,017.00 EUR. In the previous year, Inventory was 688,585.00 EUR — a change of 6.02% (higher).

Inventory

730,017.00EUR

YoY

6.02%

Last updated:

Inventory of Ikonisys is 2025 730,017.00 EUR. Inventory of Ikonisys was 2024 688,585.00 EUR. It decreases by 6.02% higher compared to the previous year.

The Ikonisys Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2021
141,643.00 EUR
Jan 1, 2022
446,285.00 EUR
Jan 1, 2023
473,379.00 EUR
Jan 1, 2024
688,585.00 EUR
Jan 1, 2025
730,017.00 EUR
The Ikonisys Inventory history
YEARInventoryYoY
730,017.00EUR+6.02%
688,585.00EUR+45.46%
473,379.00EUR+6.07%
446,285.00EUR+215.08%
141,643.00EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ikonisys Stock analysis

What does Ikonisys do? Ikonisys SA generates revenue through the sale of its cell diagnostic products, including oncoFISH bladder, oncoFISH her2, oncoFISH cervical, oncoFISH PTEN, oncoFISH ALK, and Explorer applications. These products are designed for cancer diagnosis, genetic disorder detection, and fertility testing, utilizing advanced molecular and immunological markers. The company's target customers are healthcare providers and clinical laboratories seeking accurate rare cell detection solutions. Ikonisys SA's offerings are tailored to specific medical applications such as bladder, breast, cervical, prostate, lung, and hematological cancer diagnostics, leveraging its proprietary Ikoniscope robotic components and digital microscope technology. The firm's product portfolio focuses on specialized diagnostic applications, with oncoFISH solutions targeting specific cancer types through molecular marker analysis. Explorer applications support hematological cancer diagnostics, while the underlying technology combines image acquisition, software engine, and digital microscopy for reliable cell detection. Ikonisys SA serves the healthcare sector by providing tools that enable precise diagnosis of genetic conditions and cancer types through its unique cellular analysis platform. Ikonisys SA's revenue streams are derived from the distribution of its diagnostic applications to clinical settings. The company's products are sold to healthcare institutions requiring advanced diagnostic capabilities for cancer, genetic disorders, and fertility issues. By offering targeted solutions like oncoFISH bladder for bladder cancer and oncoFISH her2 for breast cancer, Ikonisys SA addresses specific diagnostic needs within the medical field, utilizing its proprietary technology stack including Ikoniscope components and digital microscopy. Ikonisys is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ikonisys stock

Inventory of Ikonisys is 730,017.00 EUR in 2025.

Inventory of Ikonisys changed from 688,585.00 EUR to 730,017.00 EUR, representing a 6.02% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Ikonisys since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Ikonisys historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Ikonisys

All Key Metrics — Ikonisys